* a strategy for releasing current development to the public is being put together and shareholders should expect many developments in the very near future.
* On top of the list is the company's patent pending probiotic for people who suffer from lactose intolerance but many other products, partnerships, and developments have been being worked on over the past two months.
* The new technology that enables the probiotic to curb lactose intolerance symptoms has many applications, putting Manzo Pharmaceuticals in the position of developing and licensing that technology creating solutions that could put the company on the map.
About Manzo Pharmaceuticals, Inc.
Manzo Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, and testing of patented and non-patented solutions and remedies.
Most notably is a patented solution for lactose Intolerance, and a natural remedy for colic in babies.
For more information follow the company on twitter at @manzopharma, and visit www.manzopharma.com
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.